Table 1.

Changes in latency to firing first action potential with drug exposure, determined at the lowest current step at which spike firing was evoked

Condition Baseline (msec) After drug exposure (msec) Change in latency (msec)*
SKF81297 + quinpirole 160 ± 35 95 ± 18 —66 ± 27
DA 162 ± 28 92 ± 14 —70 ± 25
Forskolin 179 ± 22 66 ± 17 —113 ± 24
4-AP (10 μm) 166 ± 20 77 ± 17 —89 ± 16
4-AP (60 μm) 193 ± 21 53 ± 11 —140 ± 15
α-dtx 174 ± 13 68 ± 26 —106 ± 16
  • SKF81297 and quinpirole (10 and 10 μm) and DA (75 μm) are from perforated patch experiments.

  • * p < 0.05 for all conditions; paired t test.